Innovative-solutions-for-early-peripheral- arterial-disease-diagnosis2

How did MESI ABPI MD and MESI mTABLET ABI make ABI measurement accessible to all patients at risk for PAD?

According to multiple international guidelines on Peripheral Arterial Disease (PAD), it’s important to discover blocked arteries in the early stage to prevent serious complications. The disease can otherwise result in dangerous outcomes, such as heart attack, stroke, ulceration or amputation. Moreover, most patients are asymptomatic, nearly 70% of the patients do not feel any pain or changes in the lower extremities.

Current guidelines recommend screening for PAD in primary care setting using Ankle-Brachial Index (ABI) in all patients with cardiovascular risks. These requirements, however, are not always fulfilled because the traditional method of measurement is cumbersome and time-consuming.

Ankle-Brachial Index (ABI) measurements with standard devices like the handheld Doppler probe are time-consuming and require trained operators. They require specialized staff, thus making ABI measurements with traditional methods not easily to a wider public, which can result in many patients with PAD going undetected and untreated. MESI ABPI MD successfully fills this gap and makes screening more efficient and convenient.

Since primary care physicians are in a pivotal position within the healthcare system to improve the standard of care for patients with PAD, introducing medical devices solving their challenges has been long overdue. Being aware of the situation MESI developed two innovative devices, MESI ABPI MD and MESI mTABLET ABI.

While MESI ABPI MD is a tool for simple, repeatable and reliable ABI measurement, MESI mTABLET ABI offers integration into a modern healthcare practice and expansion of its functionalities. Its core, the certified medical grade tablet is easily expandable with additional modules, such as Blood Pressure, digital Electrocardiogram, Pulse Oximeter, Spirometry system or Toe-Brachial Index.


The MESI ABPI MD was first introduced to the European market in the year 2014. The ABPI MD is used for early detection of Peripheral Arterial Disease in general practices, cardiology, vascular surgery, compression therapy and wound care, nephrology, angiology, diabetology, neurology, and orthopaedic surgery.

The main advantage of the MESI ABPI MD is that the measurement is performed in significantly less time (total measurement procedure can be done in a few minutes) than with traditional methods, which can take up to 30 minutes.

The measurement is accurate, completely simultaneous, and totally automatic, which minimizes the need for training and can be performed by a nurse. The measurement is accompanied by a pulse waveform recording and the measurement report can be printed out.

The MESI ABPI MD uses oscillometry and volume plethysmography, and, thanks to the PADsense™ algorithm, provides reliable results even in patients with very low ankle pressures. Regulated inflation and deflation of the cuffs within one minute provides a risk-free measurement, eliminating human error and changes in blood pressure, which occur even over a short period of time. As the 3CUFF™ measurement is completely simultaneous, there is also no need for rest time.


MESI mTABLET ABI is a completely digital Ankle-Brachial Index measuring device and was introduced to the market in 2019. MESI mTABLET ABI is available as one of the modules of MESI mTABLET, a medical-grade tablet computer, and enables fast ABI measurements, result-reviewing and patient data management within one device.

The MESI mTABLET diagnostic system is a comprehensive system of top-notch diagnostic modules, designed and produced particularly for use in primary health care.

Specifics of the medical environment were taken into consideration during the development process, resulting in the portability and flexibility of the device. It was developed in accordance with the growing needs of medical personnel; therefore, it is easy to use and can be effortlessly introduced into healthcare working environment. MESI mTABLET brings a completely digital patient database and an excellent user experience.

MESI mTABLET ABI represents the wireless and completely digital version of the existing MESI ABPI MD device. It is equipped with the unique 3CUFF™ technology, providing simultaneous ABI measurement, while automatically considering the higher of the two arm blood pressures. It also features the indispensable PADsense™ algorithm for detection of severe Peripheral Arterial Disease (PAD).

Smart, tubeless cuffs, which come together with the device, are available in multiple sizes. The cuffs offer reliable performance, extended durability and are easy to clean, while their error detection algorithms ensure reliable result every single time.

The corresponding MESI mRECORDS web platform enables detailed measurement review and analysis of left and right Ankle-Brachial Index, full oscillation graph, pulse waveform, as well as trends and follow-up measurements with a history review. It also allows consulting a specialist or exporting the recordings to PDF and printing. MESI mRECORDS is always up to date, featuring the latest tools. Performance and functionality can be enhanced at any time with numerous software and diagnostic tools available in the medical marketplace – mSTORE.

Innovative-solutions-for-early-peripheral- arterial-disease-diagnosis3

Main characteristics of MESI mTABLET ABI:

  • Workflow optimization
    It is ready to be integrated into your existing workflow and electronic medical records. Featuring a built-in consultation, it enables secure sharing of measurements with other medical staff.
  • Efficient collaboration
    It enables organizing working groups the same way they are organized in the practice. A hand-held system provides boundless freedom in a modern healthcare facility.
  • Practice enhancement
    Empowering your daily work with additional applications and modules. Experience advanced diagnostics through unrivalled measurement upgradability options. Expand the functionalities of ABI measurements with the addition of smart applications, such as pulse wave velocity and central blood pressure.
  • Securing your data
    It complies with strictest security standards.